Benefits Of 5KL Bioreactor When Outsourcing Late-Phase Biologics Drug Substance Manufacturing

When you look at the current challenges in upstream bioprocessing, two come to the forefront as critical. The first is intensified cell culture processes which present a challenge for the bioreactor space—specifically for improving the mixing and mass transfer of performance. The second is a demand for flexible and efficient manufacturing which is driven by a shift in volumetric demand profiles.

Watch this webinar today and discover how Thermo Fisher Scientific is addressing and overcoming these two challenges of bioprocessing.